NCT06525948View on ClinicalTrials.gov

Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2025

Conditions

Aplastic AnemiaTransfusion-dependent Anemia

Interventions

DRUG

rhTPO

DRUG

Cyclosporin A

cyclosporine A

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER

NCT06525948 - Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA | Biotech Hunter | Biotech Hunter